SynthesisFrontiers in oncology2020

Risk of Gastrointestinal Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Systematic Review and Meta-Analysis.

Wenhan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.